Determining molecular candidates that contribute to the high risk of COVID-19 in elderly individuals

  • Funded by Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)
  • Total publications:2 publications

Grant number: 2020/04919-2

Grant search

Key facts

  • Disease

  • Start & end year

  • Known Financial Commitments (USD)

  • Funder

    Fundação de Amparo à Pesquisa do Estado de São Paulo [São Paulo Research Foundation] (FAPESP)
  • Principle Investigator

  • Research Location

    Brazil, Americas
  • Lead Research Institution

    Universidade Estadual de Campinas
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags


  • Study Subject


  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment


  • Age Group


  • Vulnerable Population


  • Occupations of Interest



COVID-19 has recently emerged as an age-related disease whose mechanisms are still poorly understood. Using a combination of hypothesis-driven and unsupervised data-based approaches, as well as patients and preclinical models, we hope to find proteins and candidate pathways that can not only predict disease susceptibility, but also unravel the molecular mechanisms through which aging contributes to SARS-Cov-2 infection. We also hope to propose drugs approved by the FDA and ANVISA that can potentially target these pathways to prevent, mitigate or eliminate viral infection. Our general objective is to elucidate how aging constitutes the main risk factor for COVID-19, providing possible solutions for its pandemic.

Publicationslinked via Europe PMC

Last Updated:37 minutes ago

View all publications at Europe PMC

Diving into the proteomic atlas of SARS-CoV-2 infected cells.

Increased mTOR Signaling and Impaired Autophagic Flux Are Hallmarks of SARS-CoV-2 Infection.